A Study to Determine the Number of Participants With Rheumatoid Arthritis (RA) Who Meet the Requirements for Treatment With Anti-Tumor Necrosis Factor α (TNFα) in a General Hospital Setting in Korea

Completed

• Conditions: Rheumatoid Arthritis

• Registration Number: NCT01294722
• Lead Sponsor: Janssen Korea, Ltd., Korea

Brief Summary

This is an observational study to estimate the proportion of patients diagnosed with RA visiting a medical internist in a general hospital in Korea who are candidates for anti-TNF α therapy.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2011-02-10
• Study First Submitted QC: 2011-02-10
• Study First Posted: 2011-02-11
• Study Start: 2011-12
• Primary Completion: 2012-08
• Study Completion: 2012-08
• Status Verified: 2013-03
• Last Update Submitted: 2013-03-18
• Last Update Posted: 2013-03-19

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 1700

Inclusion Criteria

• Diagnosed with RA
• Visiting a medical internist in a study site during the study period on out patient basis
• Able to give written informed consent voluntarily

Exclusion Criteria

None

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Number of anti-TNF α agent candidates fulfilling the reimbursement guideline of Korea government in total out-patients with RA	Baseline
Number of anti-TNF α agent candidates based on the clinical judgement in total out- patients with RA	Baseline